Staff Profile
Dr Ruth Norris
Research Associate
- Telephone: 0191 208 2271
Ruth is a researcher within the Population Health Sciences Institute (PHSI) at Newcastle University. She is also a registered pharmacist.
Ruth completed her MPharm degree at Durham University before moving to Newcastle University to undertake a PhD in pharmacoepidemiology (socio-economic inequalities in the utilisation of novel anti-cancer therapies).
In 2022, Ruth took up the role of Research Associate and now works on several research projects centred around cancer epidemiology and patient safety.
Ruth is Co-Deputy Lead for the NUPHSI Equality, Diversity, and Inclusion (EDI) committee and a NU Women Steering Group Committee member.
Ruth’s research to date has included: cancer treatment inequalities, medication adherence, routes to diagnosis, and survival outcomes. Primarily this work has focused on lung, breast, and head and neck cancers through statistical analyses of national cancer registration data. Additional quantitative work has involved using GP primary care data. Ruth has a real interest in understanding and reducing inequalities in cancer care.
Currently Ruth is based within Newcastle's Patient Safety Research Collaboration (PSRC) which aims to undertake research with the goal of improving healthcare safety where there are inequalities for those from disadvantaged communities. Investigating and explaining contemporary patterns and trends in inequalities (by region and deprivation) across the head and neck cancer pathway is an initial focus of Ruth's PSRC work.
Ruth also works on the Supporting Women with adhErence to hormonE Therapy following breast cancer (SWEET) project. This aims to assess a whether a theoretically-informed intervention can help reduce poor adherence, improve health-related quality of life (HRQoL), and reduce long-term recurrence in women prescribed hormone therapy for oestrogen receptor positive (ER+) breast cancer.
Ruth is a qualified teacher (PGCE, Durham University) and has previously worked for several years as an educator. She has helped with both Masters of Public Health and summer intern (methodology epidemiology) student supervision. Ruth has also supported the supervision of Academic Clinical Fellows in Medical Oncology.
-
Articles
- Norris RP, Dew R, Greystoke A, Cresti N, Cain H, Todd A, Sharp L. Sociodemographic Disparities in HER2+ Breast Cancer Trastuzumab Receipt: An English Population-Based Study. CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION 2024, 33(10), 1298-1310.
- Todd A, Waldron C, McGeagh L, Norris R, Bolnykh I, Stewart SJ, Slodkowska-Barabasz J, Moon Z, Cahir C, Thompson S, Harmer V, Wells M, Watson E, Sharp L. Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: a systematic review of reviews. Cancer Medicine 2024, 13(3), e6937.
- Norris RP, Dew R, Greystoke A, Todd A, Sharp L. Socio-economic Inequalities in Novel NSCLC Treatments During the Era of Tumor Biomarker Guided Therapy: A Population-based Cohort Study in a Publicly Funded Healthcare System. Journal of Thoracic Oncology 2023, 18(8), 990-1002.
- Deane J, Norris RP, O'Hara J, Patterson J, Sharp L. Who Presents Where? A Population-Based Analysis of Socio-Demographic Inequalities in Head and Neck Cancer Patients’ Referral Routes. International Journal of Environmental Research and Public Health 2022, 19(24), 16723.
- Norris R, Dew R, Sharp L, Greystoke A, Rice S, Johnell K, Todd A. Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis. BMC Medicine 2020, 18, 282.
- Rathbone AP, Norris R, Parker P, Lindsley L, Robinson A, Baqir W, Campbell D, Husband A. Exploring the use of WhatsApp in out-of-hours pharmacy services: A multi-site qualitative study. Research in Social and Administrative Pharmacy 2019, 16(4), 503-510.
-
Conference Proceedings (inc. Abstracts)
- Sharp L, McGeagh L, Stewart S-J, Longe A, Norris R, Brett J, Wells M, Watson E. Supporting Women with Adherence to Adjuvant Endocrine Theraphy - Results from the Sweet Feasibility Study. In: The Association of Breast Surgery Conference 2024. 2024, Bournemouth, UK: European Journal of Surgical Oncology.
- Norris RP, Dew R, Greystoke A, Todd A, Sharp L. OP42 Socio-economic inequalities in novel NSCLC treatments during the era of tumour biomarker guided therapy: a population-based cohort study. In: Society for Social Medicine & Population Health 67th Annual Scientific meeting. 2023, Journal of Epidemiology and Community Health.
- Norris RP, Fuller E, Greystoke A, Todd A, Sharp L. OP41 Routes to diagnosis in lung cancer – do socio-demographics matter? An English population-based study. In: Society for Social Medicine & Population Health 67th Annual Scientific meeting. 2023, BMJ.
- Norris RP, Dew R, Todd A, Greystoke A, Sharp L. OA01.05 Socio-economic Inequalities in NSCLC Treatment During the Era of Tumour Biomarker Guided Therapy: A Population-based Study. In: 2022 World Conference on Lung Cancer. 2022, Vienna, Austria: Elsevier.
- Rathbone AP, Parker P, Norris RP, Robinson A, Baqir W, Campbell D, Husband AK. Pharmacy 2.0: Experiences of using WhatsApp as a real time communication tool to deliver out-of-hours pharmacy services. In: Research in Social and Administrative Pharmacy. 2018.